12 Questions with Patrick Oliver
Patrick Oliver, General Manager of Alfasigma UK and Ireland, brings 36 years of industry expertise to the role.
Lilly invests another $3bn in its manufacturing network
Lilly will spend $3 billion on a recently acquired Wisconsin plant for injectable medicines, including diabetes and obesity drugs.
GSK builds neuro, cancer pipeline with trio of deals
GSK has added to its R&D pipeline via partnerships with Muna Therapeutics, Rgenta Therapeutics, and Duality Biologics.
A single mutation could make H5N1 flu a human threat
A single mutation in the H5N1 strain of avian influenza that is infecting cows in the US could make it more likely to infect humans, warn researchers.
The future of patient registries: Leveraging technology for ...
The healthcare industry has a growing need for real world evidence (RWE) and the capture of holistic longitudinal outcomes.
Featured Content
Editor's Picks
Editor's Picks
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
7th Treg-Directed Therapies Summit
Unravelling Treg Biology, Pioneering Best-in-Class Approaches & Demonstrating Clinical Efficacy to Advance Validated Therapeutic Options in Autoimmunity, Inflammation & Beyond
Welcome to the Bacteriophage Therapy Summit!
Combating Antibiotic Resistance with Effective & Sustainable Phage-Based Therapies
Biotech Showcase marking 17 years of innovation and opportun...
Biotech Showcase is a cornerstone of the life science industry, with a 17-year history of connecting private and micro- to mid-cap biotech companies with top-tier investors and biopharmaceu
6th Supply Chain & Logistics for Cell & Gene Therapies Summi...
The successful delivery of CGTs hinges on the development of scalable and resilient supply chains that can meet difficult logistical requirements and temperature controls.
2nd Peptide-Based Therapeutics Summit
With Merck’s oral PCSK9 inhibitor demonstrating strong phase 3 trial results, J&J’s IL23R antagonist peptide continuing its phase 3 journey, and Chugai advancing peptides into the intracellular